HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer
Clinical trial NCT05246982 · UNKNOWN
Trial details
- NCT number
- NCT05246982
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2023-12-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.